SQUARZONI ANGELICA

Squarzoni, A., Donzelli, E., Alberti, P., Ballarini, E., Rodriguez Menendez, V., Scuteri, A., et al. (2023). EXPLOITING HDAC6 SPECIFIC INHIBITORS TO REDUCE OHP-INDUCED NEUROTOXICITY. In PNS Abstracts 2023 (pp.141-142) [10.1111/jns.12585]. Dettaglio

Squarzoni, A., Alberti, P., Donzelli, E., Scuteri, A., Cavaletti, G. (2023). HDAC inhibitors as antineoplastic and neuroprotective drugs: in vitro assessment. In Abstract book. Dettaglio

Squarzoni, A., Donzelli, E., Alberti, P., Ballarini, E., Rodriguez Menendez, V., Scuteri, A., et al. (2023). Histone deacetylases inhibitors: a new frontier for neuroprotection?. In Abstracts of the Thirteenth Annual Meeting of the Italian Association for the study of the Peripheral Nervous System (ASNP), 25-27 May 2023, Naples, Italy (pp.46-46). WILEY [10.1111/jns.12550]. Dettaglio

Squarzoni, A., Donzelli, E., Alberti, P., Scuteri, A., Cavaletti, G. (2022). Exploiting the double-effect of HDACi as therapeutic tool against cancer. Intervento presentato a: NeuroMI 2022 Annual Meeting, Milano, Italia. Dettaglio

Squarzoni, A., Scuteri, A., Cavaletti, G. (2022). HDACi: The Columbus’ Egg in Improving Cancer Treatment and Reducing Neurotoxicity?. CANCERS, 14(21) [10.3390/cancers14215251]. Dettaglio